Waverly Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Sell |
16,340
-5,742
| -26% | -$726K | 0.02% | 485 |
|
|
2025
Q1 | $2.82M | Buy |
22,082
+62
| +0.3% | +$7.93K | 0.03% | 406 |
|
|
2024
Q4 | $2.91M | Sell |
22,020
-164
| -0.7% | -$21.7K | 0.05% | 313 |
|
|
2024
Q3 | $3.23M | Buy |
22,184
+99
| +0.4% | +$14.4K | 0.06% | 254 |
|
|
2024
Q2 | $3.03M | Buy |
22,085
+10,865
| +97% | +$1.49M | 0.06% | 251 |
|
|
2024
Q1 | $1.54M | Buy |
11,220
+5,006
| +81% | +$687K | 0.04% | 301 |
|
|
2023
Q4 | $844K | Sell |
6,214
-599
| -9% | -$81.4K | 0.03% | 239 |
|
|
2023
Q3 | $833K | Buy |
+6,813
| New | +$833K | 0.04% | 214 |
|
|
2022
Q2 | – | Sell |
-2,618
| Closed | -$341K | – | 214 |
|
|
2022
Q1 | $341K | Hold |
2,618
| – | – | 0.03% | 149 |
|
|
2021
Q4 | $341K | Buy |
2,618
+920
| +54% | +$120K | 0.03% | 148 |
|
|
2021
Q3 | $261K | Hold |
1,698
| – | – | 0.02% | 183 |
|
|
2021
Q2 | $288K | Hold |
1,698
| – | – | 0.03% | 157 |
|
|
2021
Q1 | $258K | Sell |
1,698
-500
| -23% | -$76K | 0.03% | 150 |
|
|
2020
Q4 | $373K | Hold |
2,198
| – | – | 0.04% | 109 |
|
|
2020
Q3 | $287K | Buy |
+2,198
| New | +$287K | 0.04% | 116 |
|
|
2014
Q1 | – | Sell |
-234
| Closed | -$18K | – | 767 |
|
|
2013
Q4 | $18K | Hold |
234
| – | – | 0.01% | 470 |
|
|
2013
Q3 | $16K | Buy |
+234
| New | +$16K | 0.01% | 385 |
|